What is the recommended dosage for Bacillus coagulans?

General: 1-2 billion CFU/day; Ibs Support: 2 billion CFU/day (GBI-30 6086 strain)

What are the side effects of Bacillus coagulans?

Potential side effects include: Mild gas during initial use (generally less than other probiotics due to spore form), Occasional bloating, Rare loose stools.

What is Bacillus coagulans and how does it work for gut health?

Bacillus coagulans is a spore-forming probiotic bacterium that can survive stomach acid and reach the intestines intact, where it produces lactic acid and short-chain fatty acids. Research suggests it may help improve digestive symptoms including bloating, abdominal pain, and irregular bowel movements. Its spore-forming nature gives it exceptional stability compared to other probiotic strains.

What is the recommended dosage of Bacillus coagulans?

Clinical studies have commonly used dosages of 1-2 billion CFU (colony-forming units) per day. The strain GBI-30, 6086 (marketed as GanedenBC30) has the most clinical evidence and is typically dosed at 1 billion CFU daily. It can be taken with or without food, and its spore form means it does not require refrigeration.

Are there side effects or interactions with Bacillus coagulans?

Bacillus coagulans is generally well-tolerated with a strong safety profile in clinical trials. Some individuals may experience mild gas or bloating during the first few days of use. It should be used with caution in immunocompromised individuals, and those on immunosuppressive medications should consult their healthcare provider before use.

Bacillus coagulans

probiotic_strain

Also known as: B. coagulans, GBI-30 6086, GanedenBC30, MTCC 5856, LactoSpore

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dbacillus\u002Dcoagulans'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

About

Bacillus coagulans is a spore-forming probiotic with exceptional stability and survivability through the harsh gastric environment. Unlike most probiotics, its spore form is resistant to heat, stomach acid, and bile salts. Research suggests the GBI-30 6086 strain may help support digestive comfort in IBS by producing L-lactic acid, bacteriocins (coagulin), and enhancing short-chain fatty acid production in the colon.

How It Works

Spore-forming probiotic that survives gastric acid, bile salts, and heat; produces L(+)-lactic acid in the colon lowering pH and inhibiting pathogens; secretes bacteriocin coagulin with broad antimicrobial activity; enhances SCFA production by cross-feeding beneficial colonic bacteria.

Evidence For Conditions

Condition	Grade	Studies	Participants
Irritable Bowel Syndrome (IBS)	B	3	400	View →

Side Effects

Mild gas during initial use (generally less than other probiotics due to spore form)
Occasional bloating
Rare loose stools

Drug & Supplement Interactions

Antibiotics (spore form is more resistant than vegetative probiotics, but spacing still recommended)
Immunosuppressants (theoretical risk in immunocompromised patients)

Always inform your healthcare provider about all supplements you take.

Related Ingredients

Bifidobacterium bifidum Bifidobacterium breve Bifidobacterium lactis Bifidobacterium longum Lactobacillus acidophilus

Quick Facts

Dosage: General: 1-2 billion CFU/day; Ibs_Support: 2 billion CFU/day (GBI-30 6086 strain)
Forms: capsule tablet powder gummy
Natural Sources: Soil bacteria (not commonly found in food), Available primarily as commercial probiotic supplements
Upper Limit: Well-tolerated up to 6 billion CFU/day in clinical trials
Best Time: With meals for optimal spore germination and colonization

Evidence Summary

Irritable Bowel Syndrome (IBS) B

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.